Interview with Loretto Callaghan, CPO Head, Novartis Ireland
Ms. Callaghan, you have been in your current position as CPO Head for Novartis Ireland for about 6 years. How have you seen the organization evolve over this period? The…
Address: A Menarini Pharmaceuticals Ireland Ltd
Castlecourt
Monkstown Farm
Monkstown
Co Dublin,Ireland
Tel: 353 1284 6744
Besides Italy, where Menarini is one of the leading pharmaceutical groups, sales are mainly concentrated in Europe: Austria, Benelux, France, Germany, United Kingdom, Greece, Ireland, Portugal, Spain, Turkey and Switzerland. Menarini has now reached important positions in Eastern and Central Europe where it ranks no. 6 in the total market of this region including: Russia, Poland, Ukraine, the Baltic States, Czech Rep., Romania, Kazakhstan, Bulgaria, Belarus, Hungary, Slovak Rep., Uzbekistan, the Caucasian countries, Albania, Moldova and ex-Yugoslavia. Menarini is the leader on the market in the Baltic States, Ukraine, Belarus and ranking no. 2 in Russia and Kazakhstan.
The Menarini Group is present in the most important therapeutic areas of greatest importance, including:
cardiovascular products
astro-intestinal productsantibiotics/respiratory system productsdrugs used in diabetes
anti-inflammatory agents/analgesics
and many others.Menarini is present in these therapeutic areas with numerous products that are representing up-todate therapeutic solutions for physicians and their patients. Given the lenght and complexity of our product list, individual lists for each country can be found at the relative company site, currently under preparation.
Menarini has been one of the first companies to have taken advantage of European decentralised registrations. Over the past nine years as many as ten products have been registered with this method. As proof of the quality of the products and of the registration dossiers presented, seven products were simultaneously registered in all Community member countries, which is quite a rare event.
In the international pharmaceutical market, today Menarini is a highly experienced company in new product registrations within the European area.
Ms. Callaghan, you have been in your current position as CPO Head for Novartis Ireland for about 6 years. How have you seen the organization evolve over this period? The…
Ms. Kelly, you have been General Manager of this affiliate since the creation of Astellas in 2005, and have overseen, since 2006, the local implementation of Astellas’ VISION 2015. How…
Dr. Edwards, you have been both a lecturer and a researcher. What made you ‘come over to the dark side’ and become a manager? I do not find it to…
Lilly has invested over one billion EUR in its Kinsale site to date—including a recent 330 million EUR expansion that positions Ireland as a key location for Lilly’s biotech pipeline.…
The Irish pharmaceutical industry employs more than 50,000 people, and generates more than 50% of Irish exports. How would the Minister sum the importance of this sector to the Irish…
In 2010, you gave a lecture for the Great Place to Work Institute, and spoke about how you have navigated the change and rapid growth MSD Ireland has experienced in…
Mr. Mazeman, can you please begin by offering a brief overview of your career to date? I am a French pharmacist by training, with expertise in pharmacology. I have worked…
You established Menarini’s Irish affiliate in 1999. How have you seen the market evolve over these last 13 years? The major changes in the market have principally occurred in the…
Celgene just announced very impressive second quarter results for its global operations, with a 38% increase in revenue partly led by strong growth in Europe. Within the global performance of…
See our Cookie Privacy Policy Here